To hear about similar clinical trials, please enter your email below
Trial Title:
Exercise For Fighting Oncology Repercussions After Treatment
NCT ID:
NCT05980325
Condition:
Neoplasms
Conditions: Official terms:
Neoplasms
Conditions: Keywords:
Neoplasms
Exercise Therapy
Side Effects
Cancer-related Fatigue
Quality of Life
Study type:
Interventional
Study phase:
N/A
Overall status:
Not yet recruiting
Study design:
Allocation:
Randomized
Intervention model:
Parallel Assignment
Primary purpose:
Treatment
Masking:
Single (Outcomes Assessor)
Intervention:
Intervention type:
Behavioral
Intervention name:
Nordic Walking
Description:
A 12-week Nordic Walking exercise programme supervised twice weekly
Arm group label:
Nordic Walking
Intervention type:
Behavioral
Intervention name:
Aquatic Exercise
Description:
A 12-week water-based exercise training programme supervised twice weekly
Arm group label:
Aquatic Exercise
Intervention type:
Behavioral
Intervention name:
Functional Exercise Training
Description:
A 12-week circuit-based exercise training programme supervised twice weekly
Arm group label:
Functional Exercise Training
Summary:
Cancer survival rates are currently on the verge of 70% at 5 years since diagnosis.
Recent improvements in main cancer therapies including chemotherapy, radiotherapy,
surgery and immunotherapy as well as developments of new biological therapies have
significantly improved survival rates but unfortunately, cancer-related side effects
continue to affect many patients even years after completion of main treatments. Exercise
has been shown to not only ameliorate cancer-related effects before, during and after
treatment but also improve disease-free and overall survival rates by decreasing risk
factors associated with cancer risk and improving resilience to treatment. In this
non-randomised, three-arm study, we aim to assess the effects of three forms of exercise
(i.e: Nordic Walking, Aquatic Exercise and Functional Exercise) on physical performance,
cancer-related fatigue, health-related quality of life and cancer-specific symptoms in a
wide range of cancer survivors.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- Adults diagnosed with cancer
- Completion of any cancer therapy in the previous 3 months with the exception of
hormonal therapy
- Patients living within the Maresme Area
- No contraindications for exercise (oncology clearance or Physical Activity Readiness
Questionnaire negative)
Exclusion Criteria:
- Patients with any neurologic, cognitive or musculoskeletal impairments that prevent
them to engage in any assessment test or exercise modality.
- Patients with unstable cardiac, respiratory or metabolic diseases
- Unable to speak or read Catalan or Spanish
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Start date:
January 1, 2024
Completion date:
July 1, 2025
Lead sponsor:
Agency:
Universitat Pompeu Fabra
Agency class:
Other
Collaborator:
Agency:
Col·legi de Fisioterapeutes de Catalunya
Agency class:
Other
Collaborator:
Agency:
Ajuntament de Mataró
Agency class:
Other
Source:
Universitat Pompeu Fabra
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05980325
